Cervical cancer remains a major health issue, particularly in developing countries, and this study aims to evaluate the real-world treatment outcomes and factors affecting patients with locally advanced cervical cancers (LACC).
A review of medical records from a French Cancer Care Center revealed that out of 94 patients treated between 2004 and 2014, conventional treatment approaches included radiotherapy and concurrent chemotherapy, with only 43.6% receiving the recommended standard care.
The findings showed a 61.9% five-year overall survival rate and identified poor performance status, lymph node metastasis, and lack of optimal treatment as significant prognostic factors affecting patient outcomes.